de
- 01
Eli Lilly und Gesellschaft
LLYNYSEUnited States
$1.12T
+6.6% 1W·+56.6% 1Y
- 02
Johnson & Johnson (J&J)
JNJNYSEUnited States
$615.9B
-2.3% 1W·+32.3% 1Y
- 03
AbbVie GmbH
ABBVNYSEUnited States
$504.4B
+3.2% 1W·+24.3% 1Y
- 04
F. Hoffmann-La Roche AG
ROGSIXSwitzerland
$371.7B
-9.5% 1W·— 1Y
- 05
Merck & Co. GmbH
MRKNYSEUnited States
$360.1B
+0.2% 1W·+72.1% 1Y
- 06
Novartis AG
NOVNSIXSwitzerland
$286.3B
+4.7% 1W·+14.6% 1Y
- 07
Novo Nordisk AG
NVONYSEDenmark
$170.0B
— 1W·-24.5% 1Y
- 08
Pfizer GmbH
PFENYSEUnited States
$168.6B
+4.6% 1W·— 1Y
- 09
Bristol-Myers Squibb Gesellschaft (BMS)
BMYNYSEUnited States
$122.0B
+1.1% 1W·+37.0% 1Y
- 10
Sanofi AG
SNYNYSEFrance
$97.3B
+0.6% 1W·-19.8% 1Y
Zeige 1–10 von 10